Kredenz Pharma Private Limited

Kredenz Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24290TG2016PTC109885 Incorporated 25 May 2016 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹10.97 Lakh
▲ 40.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
10 yrs
Est. 2016
Last financials
Mar 2025
Balance sheet date

About Kredenz Pharma Private Limited

Data last updated: 10 February 2026

Kredenz Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 May 2016, the company has been in operation for over 10 years.

Registered with ROC Hyderabad under CIN U24290TG2016PTC109885.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Madhukar Vempalla and Parthasarathy Rajagopalan.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. B – 10/C Ida Moula – Ali, Hyderabad, Telangana, India – 500040.

As per the financials filed for FY 2025, the company reported a revenue of ₹10.97 Lakh, a growth of 40% compared to the previous year.

The company is associated with 1 brand - Kredenz Pharma.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kredenzpharma.com.

Company Details of Kredenz Pharma Private Limited
CIN U24290TG2016PTC109885
Registration Number 109885
Incorporation Date 25 May 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. B – 10/C Ida Moula – Ali, Hyderabad, Telangana, India – 500040
  • Industry
    Pharma, Drug Formulation & Development
Company report
Kredenz Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Kredenz Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kredenz Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Kredenz Pharma Private Limited

Kredenz Pharma Private Limited operates one associated brand: Kredenz Pharma. These brands represent Kredenz Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures active pharmaceutical ingredients and intermediates for the industry. kredenzpharma.com

Competitors & Alternatives of Kredenz Pharma Private Limited

Brands and companies operating in the same space as Kredenz Pharma Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Kredenz Pharma Private Limited

Kredenz Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Kredenz Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Kredenz Pharma Private Limited

Kredenz Pharma Private Limited is audited by VIJAY CHANDRA & ASSOCIATES for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
VIJAY CHANDRA & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Kredenz Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Kredenz Pharma Private Limited

Kredenz Pharma Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Madhukar Vempalla Director 25 May 2016 10 Years 1 Months Current
Parthasarathy Rajagopalan Director 25 May 2016 10 Years 1 Months Current
Jagan Mohan Reddy Narsa Reddy Director 25 May 2016 10 Years 1 Months Current

Financials of Kredenz Pharma Private Limited FY 2025 filings available

Kredenz Pharma Private Limited reported revenue of ₹10.97 Lakh (up 40.00% YoY) for FY 2025.

Revenue · FY 2025
₹10.97 Lakh ▲ 40.00%
Premium access

Ten-year financial statements for Kredenz Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Kredenz Pharma Private Limited

Premium access

Shareholding and ownership data for Kredenz Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Kredenz Pharma Private Limited

Kredenz Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Kredenz Pharma Private Limited

View historical data on people associated with Kredenz Pharma Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Kredenz Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Kredenz Pharma Private Limited

Premium access

GST registrations and filing compliance for Kredenz Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Kredenz Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Kredenz Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Kredenz Pharma Private Limited

Premium access

MSME payment history for Kredenz Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kredenz Pharma Private Limited

Premium access

Corporate group structure for Kredenz Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kredenz Pharma Private Limited

Premium access

MCA filings and documents for Kredenz Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Kredenz Pharma Private Limited

Activity
30 Sep 2025
Kredenz Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Kredenz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
25 May 2016
Madhukar Vempalla was appointed as a Director on 25 May 2016 & has been associated with this company since 10 years 1 month.
Directors
25 May 2016
Parthasarathy Rajagopalan was appointed as a Director on 25 May 2016 & has been associated with this company since 10 years 1 month.
Directors
25 May 2016
Jagan Mohan Reddy Narsa Reddy was appointed as a Director on 25 May 2016 & has been associated with this company since 10 years 1 month.
Activity
25 May 2016
Kredenz Pharma Private Limited was registered on 25 May 2016 with Roc Hyderabad & aged 10 years 1 month as per MCA records.

Frequently Asked Questions about Kredenz Pharma Private Limited

Kredenz Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 25 May 2016 (10+ years old) and is registered under CIN U24290TG2016PTC109885.

Kredenz Pharma Private Limited reported revenue of ₹10.97 Lakh for FY 2025 (up 40.00% YoY).

The current directors of Kredenz Pharma Private Limited are:

The primary industry of Kredenz Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Kredenz Pharma Private Limited can be reached at the registered office: Plot No. B – 10C Ida Moula – Ali, Hyderabad, Telangana, India – 500040, or through the website kredenzpharma.com.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available